Financial news, mergers and acquisitions, partnerships, and alliances.
The two companies hope to provide translational researchers a faster, more comprehensive option for the design and validation of Accel-Amplicon panels.
The study demonstrates that Veracyte's new test improves upon an earlier version in its ability to identify thyroid nodules that are likely to be benign.
Pilot participants have access to a version of Clear Labs' sequencing and analysis platform that is designed for high-volume food safety and quality testing.
The company will use the funds to further develop its cloud-based alternative splicing analysis platform for drug discovery.
The financing round will support Grail's ongoing development and validation of early cancer detection products.
Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.
Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.
NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.
In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.